-
Spotlight on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis
A recent publication in Gastroenterology provides an in-depth overview of the latest guidelines for the pharmacological management of moderate-to-severe ulcerative colitis (UC). The evolving landscape of UC treatment highlights the importance of personalized approaches, balancing efficacy, safety, and patient preferences.
-
Preventing MASLD-Related Hepatocellular Carcinoma: Insights from Clinical Gastroenterology and Hepatology
In January 2025, Clinical Gastroenterology and Hepatology published a narrative review titled “Lifestyle and Pharmacologic Approaches to Prevention of Metabolic Dysfunction-associated Steatotic Liver Disease-related Hepatocellular Carcinoma.”With MASLD (Metabolic Dysfunction-associated Steatotic…
-
Unveiling a New Perspective on Colorectal Cancer: The Role of Unresolved Inflammation
A recent study published in Gut offers groundbreaking insights into colorectal cancer (CRC), revealing that the disease may persist in a state of chronic, unresolved inflammation, akin to a poorly healing wound. Researchers utilized advanced techniques, including lipidomics, single-cell, and spatial transcriptomics, to identify a critical imbalance within the tumor microenvironment.
-
INTEGRATE IIa Phase III Study: Regorafenib Shows Survival Benefits in Refractory Advanced Gastric Cancer
Valuable researchers have delivered promising results from the INTEGRATE IIa Phase III trial, evaluating regorafenib, an oral multikinase inhibitor, in patients with refractory advanced gastric and esophagogastric junction cancer (AGOC).
-
Exploring Porto-Sinusoidal Vascular Disorder (PSVD) Beyond Portal Hypertension: Insights from the Journal of Hepatology
In January 2025, the Journal of Hepatology published a thought-provoking letter titled “Beyond Portal Hypertension: Characterizing Porto-Sinusoidal Vascular Disorder in Patients without Signs of PH.” This study sheds new light…
-
Optimizing First-Line Treatment for Advanced Biliary Tract Cancers: Insights from the Journal of Clinical Oncology
In January 2025, the Journal of Clinical Oncology published an important Grand Rounds article titled “Finding the Right Partner: Triplet Therapy for First-Line Advanced Biliary Tract Cancers.”This piece delves into…
-
The Freiburg Index of Post-TIPS Survival (FIPS): A Key Predictor for Decompensation and ACLF Risk
In February 2025, the Journal of Hepatology published a pivotal study revealing how the Freiburg Index of Post-TIPS Survival (FIPS) can effectively identify patients at high risk of further decompensation…
-
Pneumococcal Pneumonia Trends in Adults: A Decade of Shifting Patterns (2013–2023)
A recent study published in BMJ Thorax highlights significant changes in the landscape of pneumococcal pneumonia among adults hospitalized with community-acquired pneumonia (CAP) over the past decade. The data, drawn from a prospective cohort of over 5,000 patients, reveals that the proportion of CAP cases caused by pneumococcus has nearly doubled, rising from 36.4% in…
Connecting Medical Expertise through Media